Understanding how the eye protects itself from inflammation
Immune Privilege, Müller cells, and Autophagy
This project explores how special cells in the retina use a natural cleaning process to keep the eye healthy and prevent inflammation that can threaten vision.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11128561 on NIH RePORTER |
What this research studies
The eye has a unique ability to prevent inflammation, which is crucial because even minor swelling can threaten your vision; this special protection is called "immune privilege." We know that certain cells in the retina, called Müller cells, are very important for keeping the eye healthy and can even reduce inflammation. This project aims to understand if these Müller cells use a natural cell recycling process, called autophagy, to help maintain the eye's anti-inflammatory environment. Researchers will use models of eye inflammation to see how Müller cells and autophagy work together to protect the eye.
Who could benefit from this research
Good fit: This foundational research does not directly involve patients, but future studies based on this work may seek individuals with autoimmune eye conditions like uveitis or those at risk of vision loss from inflammation.
Not a fit: Patients without eye inflammation or autoimmune conditions are unlikely to directly benefit from this specific basic science project.
Why it matters
Potential benefit: If successful, this work could lead to new ways to treat or prevent vision loss caused by autoimmune eye diseases and other inflammatory conditions.
How similar studies have performed: While the individual components (immune privilege, Müller cells, autophagy) are known, the specific connection between Müller cells and autophagy in maintaining immune privilege in the eye is a novel hypothesis being tested.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Ferguson, Thomas Almon — Washington University
- Study coordinator: Ferguson, Thomas Almon
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.